© 2019 The Sonder Group

One of the markets that’s got the industry most excited lately is personalized medicine – the use of detailed diagnostics to determine individualized medical treatments. Little wonder that the approach is garnering attention, as the number of stakeholders seeing new ways to benefit seems to grow daily. Think platform tool providers, whose imaging and genetic tests are going to be relied on in completely new ways. Think pharma companies, who’ll be able to increase their shot at getting drugs through clinical trials by weeding out non-r...

Please reload

Follow Us
  • LinkedIn Social Icon
  • Twitter Basic Square
  • Facebook Social Icon